To investigate the role of thyroxine-binding globulin (TBG) and albumin in the availability of thyroid hormones to peripheral tissues, comprehensive kinetic studies of thyroxine (T4) and triiodothyronine (T3) were carried out in eight subjects with familial dysalbuminemic hyperthyroxinemia (FDH), in four subjects with inherited TBG excess, and in 15 normals. In high-TBG subjects, the reduction of T4 and T3 plasma clearance rates (by 51% and 54%, respectively) was associated with normal daily productions; T4 and T3 distribution volumes were significantly reduced. In FDH subjects T4 clearance was less reduced (by 31%) than in high TBG; consequently T4 production rate was significantly increased (by 42%), T4 and T3 distribution volumes and T3 clearance rate were unchanged. Increased T3 peripheral production in FDH (by 24%) indicates that T4 bound to abnormal albumin is more available to tissues than T4 carried by TBG, thus suggesting an important role of albumin in T4 availability to the periphery.
Introduction
Familial dysalbuminemic hyperthyroxinemia (FDH)' and familial elevation of thyroxine-binding globulin (TBG) are two hereditary abnormalities ofthe interaction between thyroid hormones and their binding proteins, both leading to euthyroid hyperthyroxinemia (1) (2) (3) (4) (5) (6) (7) . In the former, the serum thyroid hormone excess is due to an albumin molecule with an abnormal binding site having a much greater affinity for thyroxine (T4) ; in the latter, hyperthyroxinemia is due to an increased serum concentration of TBG. Absolute T4 and triiodothyronine (T3) Receivedfor publication 7 July 1986 and in revisedform 30 December 1986.
1. Abbreviations used in this paper: CR, conversion ratio; FCR, fractional catabolic rate; FDH, familial dysalbuminemic hyperthyroxinemia; IDV, initial distribution volume; MC, multicompartmental; MCR, plasma (or metabolic) clearance rate; NC, noncompartmental; Qt. total extrathyroidal body pool; rT3, reverse triiodothyonine; SR, secretion rate; T3, triiodothyronine; T4, thyroxine; TBG, thyroxine-binding globulin; TDV, total distribution volume; TR, transfer rate. serum free concentrations are, however, normal in both conditions. Although it is widely recognized that only the unbound hormone fraction is available to enter tissues, some experimental evidence suggests that also a portion of albumin-bound T4 is readily available for transport (8, 9) . In contrast, more recent studies in FDH (10) and in rats injected in the portal vein with serum from FDH subjects (1 1), have ruled out a specific role for albumin, different from TBG, in the transport of T4 into cells. It should be noted that this conclusion has been based on T4 kinetic studies, whereas the data on T3 kinetics are few and incomplete (1) .
Because most of the circulating T3 normally arises from T4 to T3 conversion in peripheral tissues rather than from direct thyroidal secretion, we carried out simultaneous T4 and T3 turnover studies in subjects with altered thyroid hormone-binding protein interaction, aiming at a further definition of the role of TBG and albumin in the transport and distribution of thyroid hormones. Both noncompartmental and multicompartmental methods were used for data analysis. The latter approach appears to be particularly useful inasmuch as it allows estimating the partition of extrathyroidal hormones among the various tissues and measuring the unbiased T3 production rate (PR) and the total body T3 pool (Qt) and a direct in vivo quantification ofthe T3 thyroidal secretion rate (SR). The overall T4 to T3 conversion ratio (CR), and the relative contribution to peripheral T3 neogenesis of the "fast or slow" exchanging tissue pools can also be assessed when using a multicompartmental description of the thyroid hormone system. The noncompartmental analysis, in contrast, was also used to compare the kinetic results of the present study with those previously reported.
Methods
Subjects, protocol, and analytical procedures A total of 28 turnover studies were performed: eight subjects from five families with FDH, four men and four women, ranging in age 31-71 yr, four women from three families with congenital elevation of TBG, aged 48-67 yr. 15 normal subjects, 10 men and 5 women, served as the control group. All subjects were euthyroid by clinical and laboratory data ( Table  I) . Measurements of total T4, total T3, thyrotropin (TSH), and reverse T3 (rT3) in the serum were performed by specific radioimmunoassays immunodiffusion (Behring, Berlin, Federal Republic ofGermany). Thyrotropin-releasing hormone (TRH) stimulation tests were performed by intravenous bolus injection of 200 jig of TRH (Biodata, Milan). The distribution oftracer concentrations of 125I-T4 among serum carrier proteins of subjects with FDH was determined by polyacrylamide gel electrophoresis in Tris glycine buffer, pH 8.9 (15) .
Informed consent was obtained from each subject before the tracer experiment. All subjects received 10 drops ofsaturated potassium iodide solution per day, starting 2 d before, throughout the study. 125I-T4 (calculated sp act 200 sCi/Mgg) and "3'I-T3 (sp act 240 MCi/Mg) were prepared in our laboratory by the chloramine-T technique using a labeling procedure described previously (16) . A measured dose containing 125I-T4 (50 MCi) and '311-T3 (30 MCi) was injected intravenously as a single bolus.
Venous blood samples were taken at frequent intervals for the first 24 h (0.08, 0.25, 0.5, 0.75, 1, 2, 4, 8, 12, 18, 24 h), then every 12, 24 h until 144-192 h after injection, and the plasma disappearance curves of 125I-T4 and '3'1-T3 and concentrations of '25I-T3 newly formed from 5'-monodeiodination of tracer '25I-T4 were determined by a chromatographic system using Sephadex G-25 (Superfine, Pharmacia, Uppsala, Sweden) as previously described (12) . This method allows quantitative recovery and complete separation of labeled T4 and T3 from their labeled metabolites.
Binding studies
Measurement of thyroxine binding to TBG. TBG was separated from other T4-binding proteins by adsorption ofthe serum glycoprotein fraction on concanavalin A-Sepharose 4B (Con A-Sepharose) (17, 18) . 100 M1 of T4-free serum (diluted 1:20 with phosphate-buffered saline [PBS]) was added to several test tubes containing 200 Ml of a slurry ofCon A-Sepharose previously washed and diluted (1:1) with PBS (0.01 M phosphate buffer, 0.15 M NaCl, pH 7.4). The mixture was incubated for 30 min at room temperature with frequent mixing, and then allowed to settle. The supernatant was discarded and the gel sediment was washed twice with 1 ml of PBS. The gel was then reacted with 1 ml of a variable amount of unlabeled T4 and '25I-T4 in a water bath at 370C for 1 h, with frequent mixing. The mixture was allowed to settle for another hour, then the supernatant was carefully aspirated and the sediment was counted in a gamma counter. Binding data were analyzed according to Scatchard (19) after correction for nonspecific binding.
Measurement ofT4 binding to albumin. Serum albumin was separated from other T4-binding proteins by affinity chromatography on Cibacron Blue F3GA immobilized on agarose (Blue Sepharose) (20) , after removal of TBG by adsorption on Con A-Sepharose. Briefly, 100 Ml of whole serum was applied to a microcolumn of Con A-Sepharose (2 X 0.9 cm) equilibrated with PBS, and eluted with 2 ml of buffer. The eluate was then applied to a column ofBlue Sepharose (2 X 0.9 cm), and the albumin was eluted with 1.5 M NaCl in buffer. The albumin fraction was diluted 1:5 with PBS to lower its salt content. Binding of T4 to albumin was assessed by a modification of the competitive binding technique employing Sephadex G-25 (21). 100 Ml of the diluted albumin fraction was added to several test tubes each containing 200 mg of Sephadex G-25 (medium) preequilibrated with PBS. A variable amount of a solution of unlabeled T4, tracer '25I-T4, and PBS were added to the tubes to a final volume of 1.5 ml (1.0 ml in the excluded volume) and allowed to equilibrate for 1 h at 370C with frequent mixing, and then, after settling for another hour, 200 Ml of the supernatant was counted. Separate experiments were performed in the same range ofT4 concentrations but without serum proteins to estimate T4 binding by Sephadex. The calculation of the albumin-bound T4 was performed according to the original procedure (21), and the binding data were analyzed by the Scatchard method.
Kinetic studies Noncompartmental approach. Standard noncompartmental (NC) formulas (22) (23) (24) were used to analyze the plasma disappearance curves of 125I1T4 and of '"'I-T3. The following turnover and distribution parameters were computed for both T4 and T3 kinetics: plasma (or metabolic) clearance rate (MCR), initial distribution volume (IDV), total distribution volume (TDV), production rate (PR), total extrathyroidal pool (Q.), and fractional catabolic rate (FCR). FCR = MCR/TDV = PR/Qt.
The values ofthe areas and first-order moments ofthe disappearance curves to be used in NC formulas were computed starting from intercepts and slopes of multiexponential functions (sums of three exponentials), fitted (by least squares) on the experimental plasma 125i1T4 and I3I-T3 data.
The plasma appearance curve of 1251-T3 generated in vivo from the injected 125I-T4 was used to estimate the 14 to T3 conversion ratio (CR) using a convolution approach previously described (12, 25, 26) . The peripheral production rate of T3 was then obtained as the product of the T4 production rate by the T4 to T3 CR (after correction for the T3/=4 molecular weight ratio); the thyroidal T3 secretion rate (T3 SR) was obtained as the difference between the total T3 production rate (T3 PR) and the peripheral T3 production rate.
Multicompartmental approach. The assumptions and limitations of the NC approach have been previously discussed in detail (26, 27) . In brief, the NC approach relies on the assumption that both the production and the disposition of the tracer take place in the central (plasma) pool. (30) . Moreover, the same approach does not yield reasonable interval estimates for the rates of T3 production from T4 conversion, because the parameters k52 and k63 cannot be estimated individually but only in the combinations (ko2 + k52) and (ko3 + k63), which are the cumulative outputs from the peripheral T4 pools. In fact, the conversion ratio, computed in cardiac patients according to this method, was determined within rather large bounds (67% on average) (30).
To obtain narrower interval estimates for the parameters of T3 kinetics, we exploited the experimental data of the appearance curve of labeled T3 generated in vivo from the conversion of the injected labeled T4. In our approach, the best fit of this latter experimental curve 'I-Q, the theoretical curve computed on the basis of the complex six-pool model allowed the computation ofthe products k45 X k52 and k46 X k63. These products are associated with the pathways through which the T3 generated from T4 deiodination in the fast or the slow pool reaches the sampling compartment (compartment 4). This additional datum allows computing the thyroidal T3 secretion rate and to constrain the parameters of T3 kinetics within narrower bounds. In particular, the T3 production rate in our normal subjects could be determined within intervals of 6% on the average (range 1.0-8.8%) whereas the T4 to T3 conversion ratio was obtained with bounds of 8.1% (range 0.6-17.8%).
The computed kinetic parameters ofthe complex six-pool model are reported in this paper as mean population values (see Fig. 8 ); note that, although thyroidal secretion rates of T4 and T3 and the masses of central pools of T4 and T3 are directly identified, all the other parameters are reported as the midpoints of their computed bounds.
Statistical analysis
Values are given as mean±standard deviation or standard error of the mean. Student's t test was used to compare population means.
Results

Binding studies
The diphasic Scatchard plot obtained in the binding studies of albumin in FDH subjects pointed out the occurrence of two classes of binding sites. Affinity constants (Ka) and binding site concentrations calculated from these plots for the high-affinity sites were assumed to represent the affinity and the molar concentration of the abnormal albumin.
The mean values of the measured T4 affinity constant of albumin and TBG binding sites in FDH and in high-TBG sub- Fig. 2 . In FDH the percentage of T4 carried by albumin (41.2±6.3%) was significantly increased and, consequently, the percentage of T4 carried by TBG was significantly decreased (P < 0.001). These data are in good agreement with those reported previously (4, 10).
Kinetic studies
The mean plasma curves obtained in the three study groups for '25I-T4 and '3'I-T3 are depicted in Fig. 3 together with the corresponding fitting functions. It can be seen that the disappearance curve of labeled T4 of high-TBG subjects is slower than that of the controls, whereas the curve of FDH subjects is intermediate between the two. The plasma T3 disappearance curves ofnormals and FDH subjects are virtually superimposable, whereas high-TBG subjects exhibit a remarkably slower decay rate. Fig. 4 shows the plasma appearance curves, in normals and FDH subjects, of '25I-T3 newly formed in peripheral tissues (by 5'-monodeiodination oflabeled T4) together with the corresponding fitting functions computed by convolution analysis. The appearance curve of 125I-T3 in FDH subjects is clearly delayed in comparison to that observed in the controls. NONCOMPARTMENTAL ANALYSIS (TABLE III) FDH subjects. Mean values of total T4 and total T3 serum concentrations in unextracted sera (17.0±1.4 ,ug/100 ml and 141±18 ng/100 ml, respectively) were virtually identical to those measured after ethanol-butanol extraction when corrected for ex- was significantly increased (P < 0.001), because total circulating T4 was increased more than its MCR was reduced. It is noteworthy that the total serum T4 concentrations of our FDH patients varied over a wider range (15.3-19 ,ug/100 ml) than previously reported (1, 10). Moreover, a highly significant, inverse correlation was observed between T4 MCR and total T4 concentration (r = 0.96; P < 0.001, Fig. 5 ). To provide a better comparison between our findings and those of Henneman et al.
(1) and of Mendel and Cavalieri (10), our FDH patients were subdivided according to whether their T4 concentrations were lower (subgroup A) or higher (subgroup B) than 17 gg/100 ml.
In the high-T4 subgroup (B) (cases 1, 2, 3, and 6; total T4 = 18.5±0.56 ig/l00 ml, Both T4 IDV (1.73±0.15 liters/M2) and T4 TDV (4.98±1.08 liters/i2) were similar in FDH and control subjects (Table III) . Consequently, total T4 extrathyroidal body pool (Qt) was significantly increased (852±233 ;Lg/m2, P < 0.001) in comparison with normal (438±80 ,ug/m2). T4 FCR (10.0±3.6%/d) was slightly but significantly reduced (P < 0.05) in the FDH subjects as a whole, with subgroup B (6.9±2.2%, P < 0.00 1) contributing most of the change (subgroup A = 12.4±2.5%/d). The T4 to T3 conversion ratio (CR) was slightly but significantly (P < 0.05) reduced (21.0±3.8% vs. 26.1±5.9%). This was due to subgroup A (19.8±4.1%; P < 0.05) rather than subgroup B (23.1±2.3%). T3 MCR was not different from the control subjects. Consequently, the observed increment in total T3 PR (23.7%) can all be ascribed to the elevation of total serum T3 levels. Although still within the normal range, total T3 in patients (141±18 ng/ 100 ml) was significantly higher than in controls (121±12 ng/ 100 ml, P < 0.001), in accord with the findings reported by Ruiz et al. (4) . The Thyroid Subjects with inherited TBG elevation. Both T4 and T3 MCR were markedly decreased (P < 0.001), by 51.3% and 54.3% respectively, in comparison with the controls (Table III) . T4 and T3 PR were not different from normal, because the rise in serum hormone concentrations fully compensated the decrease in MCR. A significant inverse correlation was observed between T4 MCR and total T4 serum concentration (r = 0.96; P < 0.05, Fig. 5 ). It is worth noting that the decrease of T4 MCR is associated with a consensual increment of both total serum T4 and serum TBG concentrations. T4 IDV was slightly lower than normal whereas T3 IDV was significantly reduced, (P < 0.01). T4 and T3 TDV were both significantly decreased (by 28.1%, P < 0.01, and 43.5%, P < 0.00 1, respectively). T4 Qt was increased (P < 0.01) because the decrease in TDV did not counterbalance the increase in serum T4 concentration, and T3 Q. was not different in comparison with the control group. The T4 to T3 conversion ratio (22.1±1.3%) and thyroidal T3 secretion in percent of total T3 PR (26.8%) were not significantly different from the normal values. T4 FCR was significantly reduced (P < 0.001) whereas T3 FCR was only slightly decreased.
Finally, a significant inverse correlation was found to exist between the T4 to T3 conversion ratio and T4 PR (r = 0.41; P < 0.05) in the whole of the study subjects. This correlation became stronger when the data from nine hypothyroid patients previously studied by us (34) were included (Fig. 7) .
MULTICOMPARTMENTAL ANALYSIS
Normal subjects. The mean values of production rates, pool masses, and exchange fluxes ofthe T4 and T3 systems, computed according to the six-compartment model, are reported in Fig. 8 system, we also report (on the respective arrows in gg/d per m2 of T4), the production rate of T4, the exchange rates between central and peripheral compartments and the degradation rate of T4 associated to pathways different from conversion into T3. For T3 system we report (on the respective arrows in ug/d per m2 of T3), the thyroidal secretion, the peripheral production rates from T4 conversion both in the fast and in the slow peripheral compartments, the exchange rates between central and peripheral compartments and the disposal rate. The disposal rate is reported as an interval on both peripheral pools, in that the analysis does not allow identifying in which of the peripheral it refers to the peripheral T3 production only, it was more underestimated (10.6%) by NC analysis. Total T3 Qt was 25.8±5.0 ,sg/m2; NC analysis underestimated this parameter by 24.4%. Percent distribution in the initial, fast, and slow pools was 12.4%, 12.8%, and 74.8%, similar to those reported by Di Stefano et al. in rats (29) and by Hershman et al. in humans (30). It must be noted that 78% of T3 PR emanates from peripheral conversion of T4, of which 86% and 14% originate from the fast and slowly exchanging tissue pools, respectively. This is at variance with the peripheral T3 production in the rat, where the major fraction of the hormone is generated from T4 in the slowly exchanging pool (29).
FDH subjects. T4 Qt was 917±242 ,ug/m2. The 'FAST' POOLS T3 pools the degradation takes place. The following additional kinetic parameters, useful for comparing MC with NC analysis, are easily computed using the data in the figure and the mean plasma concentrations of the hormones (see Table I (Fig. 9 ). This value was underestimated by NC analysis by 9%. T4 to T3 CR was 25.6±2.9%, slightly less than normal (29.2±6.5%); this figure was underestimated by NC analysis by 18%. The mean fraction of T4 PR metabolized by other routes than T3 generation was 74%, practically superimposable to the values found in the controls (7 1%). In FDH subjects, 78.3% of the T3 PR emanates from extrathyroidal conversion from T4; this figure is identical to the corresponding normal value (78.1%). However, of this amount 57.8% and 42. of peripheral T3 production toward the slow compartment (P < 0.001) is reflected by the shape ofthe plasma appearance curve of neogenerated '25I-T3 (Fig. 4) , which appears to lag behind the normal curve. The overall T4 transfer rate (TR) from plasma, although significantly increased (P < 0.05) in absolute terms (3,281±1,267 in respect to normal value of 2,416±496 tg/d per m2) is significantly reduced (P < 0.001) when represented as percent of the plasma pool (1,108 vs. 1,871%/d). High-TBG subjects. T4 and T3 Qt were 596±37 and 25.0±6.3 ,ug/m2, respectively (Fig. 10) . These values were higher than those obtained by NC analysis (by 4.6% and 31%). For both T4 and T3 there was an increase in the amount present in the plasma pools, either in absolute terms (220±46 and 4.2±1 Ug/m2) and in percentage (respectively, 36.9% and 16.8%) in comparison with the normal situation. Overall T4 TR from plasma (1,937±379 ,ug/d per m2), although not different from normal in absolute terms, was significantly reduced (P < 0.001) in percent terms (880 vs. 1,871%/d). The mean fraction of T4 PR metabolized by other pathways than T3 generation was 75.9%, similar to the value found in the controls and in FDH subjects. Respectively, 74% and 26% of T3 generated in peripheral tissues from T4 derived from fast and slowly exchanging tissue pools.
Discussion
The present study was undertaken to investigate the specific role of serum carrier proteins of two different thyroid hormones, characterized respectively by the highest affinity (TBG) and by the highest capacity (albumin), in the availability of T4 and T3 to peripheral tissues. In vivo T4 and T3 kinetic studies were carried out in normal subjects and in individuals with congenital thyroid hormone carrier protein defects, characterized by excessive total serum T4 concentrations and by normal free T4 levels. In high TBG and FDH, euthyroid hyperthyroxinemia is due to an increase in TBG serum concentration in the former, and to the presence of abnormal albumin binding sites in the latter. The methods we used allow simultaneous in vivo assessment of T4 and T3 kinetics. In particular, the overall T4 into T3 conversion ratio, peripheral T3 production, and consequently, thyroidal T3 secretion rate can be directly measured. In addition, the amount ofT4 metabolized by other routes than T3 generation (deiodination to rT3, conjugation, decarboxylation, deamination, urinary and fecal excretion) can be estimated. The multicompartmental approach provides the partition of T4 and T3 extrathyroidal body pools among the plasma, slowly and fast exchanging tissue pools, and the relative contribution of slowly and fast exchanging compartments to peripheral T3 neogenesis.
Because MCR is defined as the ratio between disposal rate and plasma concentration, it can be considered as an index of the availability of the hormone for disposal and, in the case of T4, for its conversion into T3. It was thus found that the availability of T4 is markedly reduced in subjects with congenital elevation of TBG; their higher T4 levels ensure a normal disposal rate ofT4. In that the conversion ratio ofT4 into T3 is unchanged, peripheral T3 production remains in the normal range. The reduced T4 availability in this condition is confirmed by the significant increase (P < 0.001) ofthe initial distribution (or plasma) pool (36.9% of the total pool vs. 28 .8% of the controls) and also by the changes in T4 TR from plasma and in T4 FCR, which are reduced by 53% and 32.8%, respectively. A close reduction of T4 FCR in congenital TBG elevation has been reported also by Nicoloff et al. (35) . The reduction of T4 MCR in FDH subjects was less marked than that found in the increased TBG state, indicating that the T4 carried by abnormal albumin is more available to peripheral tissues than the T4 carried by TBG. Accordingly, both T4 TR and T4 FCR were diminished less in FDH (40% and 20%, respectively) than in TBG subjects (53% and 32.8%, respectively) in comparison with the control group. Furthermore, the higher T4 availability to peripheral tissues in FDH subjects is confirmed by their normal TDV values whereas in high-TBG subjects TDV was significantly decreased and actually superimposable on the distribution volume ofTBG itself (36). TDV values in our FDH cases were similar to those reported by Hennemann et al. (1) and Mendel and Cavalieri (10), who, however, calculated TDV values in the control subjects higher than those obtained by other authors (35, 37, 38) and by us.
Our findings are apparently in contrast with in vivo observations of Mendel and Cavalieri (10) and Hennemann et al. (1) in humans and of Cefalu et al. ( 11) in rat liver. These authors argue against a special role of albumin in FDH in T4 transport. Concerning the experimental study, the question arises whether the rat liver can serve as a valid model for studying overall T4 availability to peripheral tissues in humans. For the studies in human beings, this discrepancy could stem from differences in the methods used for the in vivo kinetic evaluation or from differences in the subjects studied. The former possibility is unlikely because the results obtained in the present study in the subjects with increased TBG and in the control group are in agreement with those reported previously (35, 37, 38) .
The highly significant, inverse correlation (r = 0.96; P < 0.001) observed between T4 MCR and the serum T4 concentration suggests the existence in FDH of a variability in the affinity and/or capacity of the abnormal albumin-binding sites. The correlation holds also when the data of Henneman et al.
(1) (r = -0.96; P < 0.001) and those of Mendel and Cavalieri (10) (r = -0.87; P < 0.001), who normalized the data by body surface area and body weight respectively, are alternatively included (Fig. 5) . It is worth noting that the affinity ofthe abnormal albumin-binding site for T4 can vary, as shown by our measurements of the Ka of abnormal albumin and T4 MCR in the same FDH subject (case 6 and 6bis) at different times; the observed reduction of Ka and of serum T4 in this subject was associated with a relatively larger increase of T4 MCR and, consequently, of T4 PR (see Table III and Fig. 5) . Although the precise mechanism responsible for this phenomenon is unknown, the explanation could include a ligand-carrier protein interaction involving a conformational change in some of the albuminbinding sites (39, 40 15.3% (not significant), and this figure is similar to the data reported by Hennemann et al.
(1) (total T4 17.7 ± 0.9 ig/100 ml, T4 PR increase 20%). In contrast, an increased T4 availability in the FDH subjects with relatively lower total serum T4 concentrations (T4 15.8 ± 0.37 ,g/!100 ml, subgroup A) is supported by the finding of a T4 MCR value not different from the control value, and ofa significant increase in the T4 production rate (see Fig. 6 ). The increase in peripheral T3 PR in the face ofan unchanged T3 thyroidal secretion, and of a small but significant reduction of T4 to T3 conversion confirms the increased T4 bioavailability. The observed decrease in the overall T4 to T3 conversion ratio and the highly significant increase in the amount ofT3 produced in slowly exchanging tissue pools suggest the presence of FDH ofa peripheral autoregulatory mechanism attenuating the effect of increased T4 availability. The significant increment in total serum T3 can be ascribed to augmented peripheral T3 PR, rather than to increased T3 affinity of the abnormal albumin-binding sites, as suggested by Ruiz et al. (4) . Our hypothesis is consistent with the finding of normal values of T3 MCR and FCR in FDH subjects, as opposed to the reduction ofthese parameters in subjects with congenital elevation of TBG (Table III) .
The consensual change oftotal serum T4 concentration and overall T4 to T3 conversion (n = 7, r = 0.70) in FDH subjects is at variance with the inverse correlation between these parameters reported by other authors and by us in subjects without alteration of thyroid hormones serum carrier proteins (12, 41, 42) . However, the overall T4 to T3 conversion ratio appears to bear a closer relationship to T4 PR than to serum T4 concentration. This is supported by the tight inverse correlation between T4 to T3 conversion and T4 PR which emerged when all the studies (normals, FDH, and high-TBG subjects, hypothyroid patients) were pooled (Fig. 7) . This finding may reflect the main peripheral tissue autoregulatory mechanism for maintaining T3 production rate and circulating T3 levels, because T4 to T3 conversion only occurs within the cells, where T4 concentration may be different from that observed in the serum. In FDH the large increase in the amount ofT4 carried by abnormal albumin molecules, and the parallel decrement in the T4 carried by TBG (Fig. 2) , can be viewed as facilitated serum hormone transport into the peripheral tissues. With regard to this, it should be borne in mind that the measured affinity constant for T4 of the abnormal albumin-binding sites was still 1,000-fold lower than the affinity constant of TBG binding sites (Table II) .
The increased bioavailability of T4 in FDH subjects, contrasted with the situation in congenital elevation of TBG, and particularly their increased T4 disposal rate suggests an independent, special role of normal albumin for T4 delivery to the peripheral tissues. This hypothesis is consistent with the finding of a dramatic increase in T4 MCR and FCR in normal or hypothyroid patients with congenital absence of TBG, where T4 is carried exclusively by albumin and thyroxine-binding prealbumin (43-46). The lack ofcorrelation between the T4 disposal rate and its free serum concentration in subjects with inherited absence ofTBG, in the face ofa normal daily T4 PR and reduced circulating free T4 levels (47), can again be explained by the higher availability for entry into the peripheral tissues ofT4 carried by normal albumin as compared with T4 carried by TBG. This is in contrast to the results reported by Cefalu et al. (1 1) , who observed that FDH albumin, like TBG, delays the uptake ofT4 by rat liver cells. However, they found a significantly greater hepatic T4 extraction from FDH serum in comparison with normal, but they did not find any difference in the concentration ofbioavailable T4 between FDH and control serum. These data are in agreement with the findings of in vivo kinetic studies in humans of Mendel and Cavalieri (10), who showed that the absolute rate of T4 flux into the rapidly exchangeable cellular compartment (liver) is normal in FDH. Both authors concluded that FDH albumin, like TBG, sequesters T4 in the plasma compartment.
In conclusion, the present study indicates that the T4 bound to FDH albumin-binding sites, although less available than T4 bound to normal albumin, still is more available to peripheral tissues than T4 carried by TBG. Our data are in agreement with those of Premacharidra et al. (48), who found enhanced rate of red cells and lymphocytes uptake of T4 from sera of FDH subjects.
In species such as man, the evolutionary development of a specific thyroxine-binding protein (TBG) is associated with a large increase in extracellular thyroid hormone reservoir, directly regulating the circulating levels of T4 and T3. On the contrary, the primary role ofalbumin-mediated hormone transport to the tissues could be based on a mechanism involving ligand-serum carrier protein interaction. In a previous paper, we provided evidence that the hormone-binding protein interaction proceeds through the fast formation ofa labile hormone-protein complex that successively rearranges to give the final complex and that the intermediate hormone-protein complex dissociates faster than the final complex. Moreover, the fraction of the T4 bound in the labile intermediate complex is 30% of the albuminbound T4 but only 0.4% of the TBG-bound T4. This implies that a definite fraction of bound hormone can be released from the carried protein in very short times (39, 49, 50) .
The consequence ofa very high dissociation rate ofa loosely albumin bound hormone is that, ifthe free hormone is lost from the bloodstream across the capillary walls, a quasi-equilibrium can be restored almost instantaneously through prompt dissociation of the bound hormone in the intermediate complex. In this way, not only is the actual free hormone made available to peripheral tissues but also a substantial part of the albuminbound hormone can be used even in tissues characterized by a short capillary transit time.
